OBJECTIVE: To assess the association of self-reported systemic and ocular comorbid disease and visual function in Latino subjects. METHODS: National Eye Institute 25-item Visual Function Questionnaire (NEI-VFQ-25) and eye examination data were obtained from 5380 participants in the Los Angeles Latino Eye Study, a population-based prevalence study of eye disease in Latino subjects 40 years and older. We developed and contrasted 5 comorbidity measures. One-way analysis of variance was used to assess the association between comorbidity and visual impairment and self-reported visual function. Regression analyses determined the association of sociodemographic variables, clinical variables, and the best measure of comorbidity with the NEI-VFQ-25 composite score. The main outcome measure was self-reported visual function as assessed by the NEI-VFQ-25 composite score. RESULTS: On average, visual function subscale scores were lowest for those participants with the most systemic comorbid conditions (P<.05). This was more evident in participants with moderate or severe visual impairment compared with those with mild or no visual impairment (P<.05). CONCLUSIONS: Self-reported systemic comorbidities were associated with self-reported visual function. This association was greater at more severe levels of visual impairment. Of the 5 comorbidity measures assessed, the measure that summed the number of self-reported systemic comorbidities correlated most with self-reported visual function.
OBJECTIVE: To assess the association of self-reported systemic and ocular comorbid disease and visual function in Latino subjects. METHODS: National Eye Institute 25-item Visual Function Questionnaire (NEI-VFQ-25) and eye examination data were obtained from 5380 participants in the Los Angeles Latino Eye Study, a population-based prevalence study of eye disease in Latino subjects 40 years and older. We developed and contrasted 5 comorbidity measures. One-way analysis of variance was used to assess the association between comorbidity and visual impairment and self-reported visual function. Regression analyses determined the association of sociodemographic variables, clinical variables, and the best measure of comorbidity with the NEI-VFQ-25 composite score. The main outcome measure was self-reported visual function as assessed by the NEI-VFQ-25 composite score. RESULTS: On average, visual function subscale scores were lowest for those participants with the most systemic comorbid conditions (P<.05). This was more evident in participants with moderate or severe visual impairment compared with those with mild or no visual impairment (P<.05). CONCLUSIONS: Self-reported systemic comorbidities were associated with self-reported visual function. This association was greater at more severe levels of visual impairment. Of the 5 comorbidity measures assessed, the measure that summed the number of self-reported systemic comorbidities correlated most with self-reported visual function.
Authors: Carolina P B Gracitelli; Ricardo Y Abe; Andrew J Tatham; Peter N Rosen; Linda M Zangwill; Erwin R Boer; Robert N Weinreb; Felipe A Medeiros Journal: JAMA Ophthalmol Date: 2015-04 Impact factor: 7.389
Authors: Roberta McKean-Cowdin; Rohit Varma; Ron D Hays; Joanne Wu; Farzana Choudhury; Stanley P Azen Journal: Ophthalmology Date: 2010-06-08 Impact factor: 12.079
Authors: D Diane Zheng; Sharon L Christ; Byron L Lam; Daniel J Feaster; Kathryn McCollister; David J Lee Journal: JAMA Ophthalmol Date: 2020-04-01 Impact factor: 7.389
Authors: Ricardo Y Abe; Carolina P B Gracitelli; Alberto Diniz-Filho; Linda M Zangwill; Robert N Weinreb; Felipe A Medeiros Journal: Am J Ophthalmol Date: 2015-04-11 Impact factor: 5.258
Authors: Felipe A Medeiros; Carolina P B Gracitelli; Erwin R Boer; Robert N Weinreb; Linda M Zangwill; Peter N Rosen Journal: Ophthalmology Date: 2014-10-16 Impact factor: 12.079
Authors: Leo S Morales; Rohit Varma; Sylvia H Paz; Mei Ying Lai; Kashif Mazhar; Ronald M Andersen; Stanley P Azen Journal: Ophthalmology Date: 2010-02 Impact factor: 12.079
Authors: Renato Lisboa; Yeoun Sook Chun; Linda M Zangwill; Robert N Weinreb; Peter N Rosen; Jeffrey M Liebmann; Christopher A Girkin; Felipe A Medeiros Journal: JAMA Ophthalmol Date: 2013-04 Impact factor: 7.389